Search research articles
Contact Us
Filters
Showing results (61-70 of 476) with videos related to
Page
of 48
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2001
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
M Venturini, A Michelotti, P Papaldo, et al.
Bone Marrow Transplantation
|
March 7, 2003
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study
C Bengala, R Danesi, V Guarneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)
C Bengala, I Pazzagli, F Innocenti, et al.
Molecular Human Reproduction
|
January 11, 2005
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens
R Mancina, S Filippi, M Marini, et al.
Journal Francais D'Ophtalmologie
|
March 1, 2014
[Battery of rockets "Scedosporium Apiospermum" in mycotic keratitis]
L Cerri, L Geroli, M Al Oum, et al.
Clinical Breast Cancer
|
March 20, 2002
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients
A Gennari, S Donati, B Salvadori, et al.
Calcified Tissue International
|
September 9, 2025
X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells
I Falsetti, G Palmini, S Donati, et al.
Physical Review Letters
|
December 11, 2014
Ultrafast Control and Rabi Oscillations of Polaritons
L Dominici, D Colas, S Donati, et al.
British Journal of Cancer
|
January 8, 2004
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
F Cappuzzo, F Mazzoni, A Gennari, et al.
Oncoimmunology
|
November 18, 2017
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy
B Montico, C Lapenta, M Ravo, et al.
Page
of 48
Search research articles
Search
Showing results (61-70 of 476) with videos related to
Sort By:
Page
of 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2001
Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients
M Venturini, A Michelotti, P Papaldo, et al.
Bone Marrow Transplantation
|
March 7, 2003
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study
C Bengala, R Danesi, V Guarneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)
C Bengala, I Pazzagli, F Innocenti, et al.
Molecular Human Reproduction
|
January 11, 2005
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens
R Mancina, S Filippi, M Marini, et al.
Journal Francais D'Ophtalmologie
|
March 1, 2014
[Battery of rockets "Scedosporium Apiospermum" in mycotic keratitis]
L Cerri, L Geroli, M Al Oum, et al.
Clinical Breast Cancer
|
March 20, 2002
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patients
A Gennari, S Donati, B Salvadori, et al.
Calcified Tissue International
|
September 9, 2025
X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells
I Falsetti, G Palmini, S Donati, et al.
Physical Review Letters
|
December 11, 2014
Ultrafast Control and Rabi Oscillations of Polaritons
L Dominici, D Colas, S Donati, et al.
British Journal of Cancer
|
January 8, 2004
Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
F Cappuzzo, F Mazzoni, A Gennari, et al.
Oncoimmunology
|
November 18, 2017
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy
B Montico, C Lapenta, M Ravo, et al.
Page
of 48